| 41/170 | US=23-C / Câncer Alnabulsi A, Carpenter B, Telfer C, Murray GI. Colorectal cancer: immunohistochemical diagnosis with heterogeneous nuclear ribonucleoprotein K. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 25-42. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; DIAGNOSTICO; IMUNOHISTOQUIMICA; RIBONUCLEOPROTEINA K; BIOMARCADORES |
| 42/170 | US=33 / Gastro Mishra R, Powell SM. Gastric cancer: molecular biology and genetics. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 245-55. ISBN 978-0-7817-7617-2. CANCER GASTRICO; BIOLOGIA MOLECULAR; GENETICA; SUSCETIBILIDADE GENETICA; GENETICA MOLECULAR; BIOMARCADORES; TUMOR ESTROMAL GASTRICO |
| 43/170 | US=33 / Gastro Stemmermann GN, Fenoglio-Preiser CM. Gastric cancer: pathology. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 257-74. ISBN 978-0-7817-7617-2. CANCER GASTRICO; PATOLOGIA; HISTOGENESE; CLASSIFICACAO; CARCINOMA GASTRICO; PROGNOSTICO; BIOMARCADORES IMUNOHISTOQUIMICOS |
| 44/170 | US=30 / Clín/Medica Barreto ML. Epidemiologia. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 110-6. ISBN 85-7379981-1. |
| 45/170 | US=4 / Gastro Khoo V. Renal cell cancer: overview and immunochemotherapy. In: Patel U. Carcinoma of the kidney. New York: Cambridge University Press, 2008. p. 1-16. (Contemporary Issues in Cancer Imaging) ISBN 978-0-521-87838-8. CANCER DE CELULAS RENAIS; CANCER DE RIM; EPIDEMIOLOGIA; IMUNOQUIMIOTERAPIA; FATORES PROGNOSTICOS; HISTOLOGIA; ESTRATIFICACAO DE RISCO CLINICO; BIOMARCADORES; TRATAMENTO |
| 46/170 | US=49-D / Câncer Cao Y. Molecular mechanisms and therapeutic development of angiogeneseis inhibitors. In: Woude GFV, Klein G. Advances in cancer research. v.100. Amsterdam: Elsevier, 2008. p. 113-31. ISBN 978-0-12-374358-9. INIBIDORES DA ANGIOGENESE; MECANISMOS MOLECULARES; DESENVOLVIMENTO TERAPEUTICO; FATORES ANGIOGENICOS TUMORAIS; VASOS SANGUINEOS; ALVOS TERAPEUTICOS; RESISTENCIA A DROGAS; MECANISMOS DE INIBIDORES; TERAPIA ANTIANGIOGENICA; QUIMIOTERAPIA; BIOMARCADORES |
| 47/170 | US=65 / Biol/Mol Lah TT, Obermajer N, Alonso MBD, Kos J. Cysteine cathepsins and cystatins as cancer biomarkers. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 587-625. ISBN 978-0-387-69056-8. CATEPSINAS; CISTEINA; CISTATINAS; BIOMARCADORES DE CANCER; PEPTIDASES; PESQUISA CLINICA; CARCINOMA DE MAMA; CARCINOMA DE PROSTATA; CARCINOMA DO COLO DO UTERO; CARCINOMA DE OVARIO; CARCINOMA DE PULMAO; CARCINOMA DE COLON; CARCINOMA DE CABECA E PESCOCO; CARCINOMA DA BEXIGA; CARCINOMA DE PANCREAS; CANCER DE FIGADO; CARCINOMA HEPATOCELULAR; MELANOMA; MENINGIOMA; GLIOMA |
| 48/170 | US=67 / Biol/Mol Dy GK, Adjei AA. Patient selection for rational development of novel anticancer agents. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 641-8. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. AGENTES ANTICANCERIGENOS; SELECAO DOS PACIENTES; TERAPIA-ALVO; BIOMARCADORES; EXPRESSAO GENICA; AMPLIFICACAO GENICA |
| 49/170 | US=67 / Biol/Mol Shankar LK, Menkens A, Sullivan DC. Molecular imaging in oncology. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 675-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. ONCOLOGIA; IMAGEM MOLECULAR; BIOMARCADORES DE IMAGEM; BIOMARCADORES IN VIVO; TESTES DE CANCER; PROCESSO NEOPLASICO; AGENTES PET; CONTRASTE AGENTES MR; TECNOLOGIA OPTICA |
| 50/170 | US=67 / Imagem Murphy PS, Roychowdhury D. Incorporating imaging into drug development: and industry perspective. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 1-15. ISBN 978-0-470-11880-1. CANCER DE PULMAO; IMAGEM; DESENVOLVIMENTO DE DROGAS; BIOMARCADORES; ENSAIOS CLINICOS |
| 51/170 | US=58 / Câncer Zhang H, Xiao Z, Sowin T. ChK1 and ChK2 as checkpoint targets. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 245-59. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. CHK1; CHK2; INIBIDORES; PARADA DO CICLO CELULAR; REVOGACAO DA RESPOSTA CHECKPOINT; CHEMOPROTECTION; BIOMARCADORES PREDITIVOS |
| 52/170 | US=70 / Biol/Mol Bunz F. Cancer genetics in the clinic. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 259-79. ISBN 978-1-4020-6783-9. GENETICA DO CANCER; CLINICA; INFORMACAO GENETICA; CARCINOGENOS; GENES; CELULAS GERMINATIVAS; ALTERACOES GENETICAS; BIOMARCADORES; TERAPIA ANTI-CANCER; BCR-ABL; IMATINIBE; GEFITINIBE; TRAIL |
| 53/170 | US=80 / Biol/Mol Sarto C, Proserpio V, Magni F, Mocarelli P. Insight on renal cell carcinoma proteome. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 121-37. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. CARCINOMA DE CELULAS RENAIS PROTEOMA; CARCINOMA DE CELULAS RENAIS; PROTEOMA; GENOMICA; BIOMARCADORES; ELECTROFORESE BIDIMENSIONAL; ANALISE SEROLOGICA PROTEOMA; MODIFICACAO POS-TRADUCAO |
| 54/170 | US=80 / Biol/Mol Gjertsen BT, Sjoholt G. Proteomic strategies of therapeutic individualization and target discovery in acute myeloid leukemia. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 161-87. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. LEUCEMIA MIELOIDE AGUDA; BIOMARCADORES; PHARMACOPROTEOMICS; ACIDO TRANS-RETINOICO; INIBIDORES DE QUINASE DE TIROSINA; HISTONA DEACETILASE INIBIDORES; INIBIDORES DE PROTEASSOMA |
| 55/170 | US=80 / Biol/Mol Brünner N, Holten-Andersen M, Sweep F, Foekens J, Schmitt M, Duffy MJ. New tumor biomarkers. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 189-207. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. BIOMARCADORES TUMORAIS; PRE-ANALITICA VARIAVEIS; VARIAVEL ANALITICA; POS-ANALITICA VARIAVEL; MARCADORES DE DETECCAO DE MARCADORES DE TRIAGEM; MARCADORES PROGNOSTICOS; MARCADORES PREDITIVOS; MARCADORES DE MONITORAMENTO |
| 56/170 | US=84-A / Biol/Mol Hsu FJ, Teicher BA, McPherson JM. Development of inhibitors of transforming growth factor-B signaling for therapy: rationale for anti-TGF-B antibody therapy in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 757-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; IMUNOSSUPRESSAO; METASTASE OSSEA; CARCINOMA DE CELULAS RENAIS; MELANOMA; CANCER DE MAMA; HORMONAL DO CANCER DA PROSTATA REFRATARIOS; CANCER DE PANCREAS; MIELOMA MULTIPLO; LINFOMA DE NAO-HOGGKIN; BIOMARCADORES |
| 57/170 | US=9 / Estatística Khoury MJ, Millikan R, Gwinn M. Special topics: genetic and molecular epidemiology. In: Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Wiilians & Wilkins, 2008. p. 564-79. ISBN 978-0-7817-5564-1. EPIDEMIOLOGIA GENETICA; EPIDEMIOLOGIA MOLECULAR; AVALIACAO DE BIOMARCADORES; ESTUDOS EPIDEMIOLOGICOS CONVENCIONAIS; QUESTOES METODOLOGICAS; ESTUDOS EPIDEMIOLOGICOS NAO CONVENCIONAIS |
| 58/170 | US=111 / Câncer Vineis P. Molecular epidemiology of cancer and the use of biomarkers. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 410-9. ISBN 978-0-470-01852-1. CANCER; CANCER; EPIDEMIOLOGIA MOLECULAR; BIOMARCADORES; MARCADORES DE DOSE INTERNA; MARCADORES DE RESPOSTA TARDIA; PROTEOMICOS; EPIGENETICA; MARCADORES DE SUSCETIBILIDADE |
| 59/170 | US=111 / Câncer Hecht SS. Tobacco use and cancer. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 429-42. ISBN 978-0-470-01852-1. |
| 60/170 | US=46 / Câncer Verma M, Kagan J, Srivastava S. DNA in neoplastic disease diagnosis. In: Meyers RA. Cancer: from mechanisms to therapeutic approaches. New Jersey: Wiley-Blackwell, 2007. p. 341-68. ISBN 978-3-527-31768-4. DNA PARA DIAGNOSTICO DE DOENCA NEOPLASICA; BIOMARCADORES; ANALISE DE CLUSTER; HYPERMETHYLATION DNA; DETECCAO PRECOCE; EPIGENETICA |